Lisa Conboy

Title: Lisa Conboy - Innovator in Psycho-Pharmaceuticals

Introduction

Lisa Conboy is a prominent inventor based in Dublin, Ireland. She has made significant contributions to the field of psycho-pharmaceuticals, focusing on innovative treatments for mental health disorders. Her work aims to improve the quality of life for individuals suffering from anxiety, depression, and cognitive impairment.

Latest Patents

Lisa Conboy holds a patent for a selective Sigma 1 or Dopamine D3 receptor agonist or a 5HT2c receptor ligand. This invention is particularly useful in treating symptoms of anxiety and/or depression associated with affective disorders, as well as symptoms related to cognitive impairment disorders. The patent includes diphenhydramine derivatives of Formula (I), specifically (2-[(4-butylsulfanylphenyl)-phenyl-methyl]sulfanyl-N,N-dimethyl-ethanamin), known as Captodiamine. This innovative approach represents a significant advancement in the treatment of mental health conditions.

Career Highlights

Lisa Conboy is affiliated with University College Dublin, where she continues her research and development in psycho-pharmaceuticals. Her dedication to advancing mental health treatments has positioned her as a key figure in her field.

Collaborations

Lisa has collaborated with notable colleagues, including Ciaran M Regan and Shane Gannon. These partnerships have enhanced her research efforts and contributed to the development of her innovative solutions.

Conclusion

Lisa Conboy's work in psycho-pharmaceuticals exemplifies the impact of innovation in addressing mental health challenges. Her contributions are paving the way for new treatment options that can significantly improve patient outcomes.